The Effect of Functional Treatment of Patients With Backward Positioned Chins on the Jaw Joint and Movements

January 31, 2020 updated by: Damascus University

The Effect of Functional Treatment Using the Activator Versus the Twin Block on the Temporomandibular Joint and the Mandibular Movements in Skeletal Class II Patients: A Randomized Controlled Clinical Trial

Patients with class II malocclusion and retrognathic mandibles will be treated using functional appliances and asses the remodeling that is expected to occur in the temporomandibular joint (TMJ) using cone-beam computed tomography (CBCT) images and we will register mandibular movements using electronic axiograph ( a specific apparatus used to record jaw movements in three dimensions).

There are three groups :

  1. Activator Group
  2. Twin block Group
  3. Control Group with no treatment.

Patients will be allocated to the three groups randomly.

Data will be collected using three different approaches:

  • CBCT images before treatment and 12 months after treatment
  • Axiograph registrations before treatment and 12 months after treatment

Study Overview

Detailed Description

The main purposes of this project are:

  1. to evaluate the remodeling effects that would take place in the bone structures of the temporomandibular joint (TMJ) during functional treatment.
  2. to evaluate the possible change that may occur in mandibular movements following functional treatment.
  3. to evaluate the possible change in the spatial relationship between centric occlusion (CO) and centric relation (CR) following functional treatment

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Damascus, Syrian Arab Republic, DM20AM18
        • Orthodontic Department, University of Damascus Dental School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Class II malocclusion Skeletal class II with retruded mandibles. Old between 10-13 years Healthy TMJ Horizontal or normal growth pattern

Exclusion Criteria:

Patients who have been treated previously Patients with syndromes or congenital deformities Signs or symptoms of temporomandibular disorders.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Activator
Patients will be treated using the Activator appliance for one and a half year
This appliance is constructed in one piece to guide the position of the mandible on closure
Other Names:
  • Andresen Appliance
Experimental: Twin Block
Patients will be treated using the Twin Block appliance for 18 months on average
This appliance is constructed in two pieces to guide the position of the mandible on closure
Other Names:
  • Clark's appliance
No Intervention: Control
Patients will be monitored until the last assessment times in the other groups. This group will serve as a control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Glenoid Fossa Height
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment

Glenoid fossa height: the vertical space between the roof and lowest edge of the fossa.

This measurement will be done on the 3D software (3D OnDemand) using CBCT images

T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in Glenoid Fossa Width
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment

Glenoid fossa width: the horizontal space between the anterior and posterior wall of the fossa.

This measurement will be done on the 3D software (3D OnDemand) using CBCT images

T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in Articular Eminence Inclination
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Articular Eminence inclination: the angle between a horizontal plane and the posterior slope of the articular eminence. This measurement will be done on the 3D software (3D OnDemand) using CBCT images
T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in Condylar Height
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Condylar Height: the vertical height of the head of the condyle. This measurement will be done on the 3D software (3D OnDemand) using CBCT images
T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in Condylar Width
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Condylar Width: the horizontal width of the head of the condyle. This measurement will be done on the 3D software (3D OnDemand) using CBCT images
T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in Condylar Length
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Condylar Length: the mesio-distal length of the head of the condyle. This measurement will be done on the 3D software (3D OnDemand) using CBCT images
T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in Condylar Circumference
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Condyle circumference: the outer circumference of the head of the condyle. This measurement will be done on the 3D software (3D OnDemand) using CBCT images
T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in the Anterior Joint Space
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment

Anterior Joint Space: the space between the anterior edge of condyle and the posterior slope of the articular eminence.

This measurement will be done on the 3D software (3D OnDemand) using CBCT images

T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in the Superior Joint Space
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment

Superior Joint Space: the space between the superior edge of the condyle and the roof of the fossa.

This measurement will be done on the 3D software (3D OnDemand) using CBCT images

T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in the Posterior Joint Space
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment

Posterior joint space: the space between the posterior edge of the condyle and the posterior board of the fossa.

This measurement will be done on the 3D software (3D OnDemand) using CBCT images

T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in Border Mandibular Movements
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Border mandibular movements will be measured on the axiograph apparatus (called Arcosdigma(R)).
T1: at one day before the commencement of treatment; T2: after 12 months of treatment
Change in the Discrepancy between CO and CR
Time Frame: T1: at one day before the commencement of treatment; T2: after 12 months of treatment
CO-CR discrepancy: we will measure distance between centric relation and centric occlusion in three dimensions (sagittal, coronal and axial ). These measurements will be done by an electronic axiograph (Arcosdigma(R))
T1: at one day before the commencement of treatment; T2: after 12 months of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Abdulmalek Majanni, DDS MSc, PhD Student in Orthodontics, University of Damascus Dental School, Damascus
  • Study Director: Issam Khoury, DDS MSc PhD, Professor of Oral and Maxillofacial Surgery, University of Damascus Dental School, Damascus, SYRIA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 15, 2018

Primary Completion (Actual)

March 19, 2019

Study Completion (Actual)

November 19, 2019

Study Registration Dates

First Submitted

August 22, 2018

First Submitted That Met QC Criteria

August 22, 2018

First Posted (Actual)

August 24, 2018

Study Record Updates

Last Update Posted (Actual)

February 5, 2020

Last Update Submitted That Met QC Criteria

January 31, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Malocclusion, Angle Class II

Clinical Trials on Activator

Subscribe